Nervgen Pharma Corp. (9UA)
Market Closed
12 Dec, 20:00
XFRA 
€
3. 66
+0.1
+2.81%
€
- Market Cap
- P/E Ratio
0% Div Yield
450 Volume
0 Eps
€ 3.56
Previous Close Day Range
3.66 3.68
Year Range
1.56 3.94
Want to track 9UA and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
| Name | Time | Cons. EPS | Eps |
|---|---|---|---|
| NGEN Nervgen Pharma Corp. 24 Nov 2025 | | - | - |
| NGEN Nervgen Pharma Corp. 19 Nov 2025 | | - | - |
| NGEN Nervgen Pharma Corp. 17 Nov 2025 | | - | - |
| NGEN Nervgen Pharma Corp. 13 Nov 2025 | | - | - |
| NGEN Nervgen Pharma Corp. 12 Nov 2025 | | - | - |
| NGEN Nervgen Pharma Corp. 20 Aug 2025 | | - | - |
| NGEN Nervgen Pharma Corp. 14 May 2025 | | - | - |
| NGEN Nervgen Pharma Corp. 7 Nov 2024 | | - | - |
| NGEN Nervgen Pharma Corp. 7 Aug 2024 | | - | - |
| NGEN Nervgen Pharma Corp. 29 Mar 2024 | | - | - |
| NGEN Nervgen Pharma Corp. 13 Nov 2023 | | - | - |
9UA Earnings Reports FAQ
What is the earnings per share (EPS) for 9UA?
The current EPS is 0.
What is the company's earnings growth rate?
Nervgen Pharma Corp has not announced its next earnings release date. You can monitor upcoming announcements in Marketlog's earnings calendar or in the company profile.
When is the next earnings release date?
Nervgen Pharma Corp has not announced its next earnings release date.
What were the most recent quarterly earnings?
The most recent quarterly earnings for Nervgen Pharma Corp are not available at this time.
What is the price-to-earnings (P/E) ratio?
There is no P/E ratio for 9UA at this time, as Nervgen Pharma Corp has no recent EPS data to calculate it.
2025 © Marketlog. All Rights Reserved.
